Abstract:This study depicted the metabolite and microbiota trajectories across aging. Long‐lived subjects from the familial longevity cohort harbored a distinguished microbiome signature. A candidate metabolite, pinane thromboxane A2 (PTA2), was consistently higher in the individuals of familial longevity and their descendants. Functional analysis showed PTA2 enhanced an anti‐inflammatory phenotype, indicating a protective role of PTA2 toward host health. Our findings provide insights into the association between gut microbiome and longevity and may facilitate the development of strategies for healthy aging. Gut microbiota associated with longevity plays an important role in the adaptation to damaging stimuli accumulated during the aging process. The mechanism by which the longevity‐associated microbiota protects the senescent host remains unclear, while the metabolites of the gut bacteria are of particular interest. Here, an integrated analysis of untargeted metabolomics and 16S rRNA gene sequencing was used to characterize the metabolite and microbiota profiles of long‐lived individuals (aged ≥90 years) in comparison to old‐elderly (aged 75–89 years), young‐elderly (aged 60–74 years), and young to middle‐aged (aged ≤59 years) individuals. This novel study constructed both metabolite and microbiota trajectories across aging in populations from Jiaoling county (the seventh longevity town of the world) in China. We found that the long‐lived group exhibited remarkably differential metabolomic signatures, highlighting the existence of metabolic heterogeneity with aging. Importantly, we also discovered that long‐lived individuals from the familial longevity cohort harbored a microbiome distinguished from that of the general population. Specifically, we identified that the levels of a candidate metabolite, pinane thromboxane A2 (PTA2), which is positively associated with aging, were consistently higher in individuals with familial longevity and their younger descendants than in those of the general population. Furtherly, functional analysis revealed that PTA2 potentiated the efficiency of microglial phagocytosis of β‐amyloid 40 and enhanced an anti‐inflammatory phenotype, indicating a protective role of PTA2 toward host health. Collectively, our results improve the understanding of the role of the gut microbiome in longevity and may facilitate the development of strategies for healthy aging.

Integrative multiomics analysis reveals host-microbe-metabolite interplays associated with the aging process in Singaporeans

Gut metagenomes of Asian octogenarians reveal metabolic potential expansion and distinct microbial species associated with aging phenotypes

Metapangenomics reveals an increased proportion of an Escherichia coli-dominated enterotype in older Chinese people

Multi-omics analysis reveals substantial linkages between the oral-gut microbiomes and inflamm-aging molecules in elderly pigs

Gut Microbiota Community And Its Assembly Associated With Age And Diet In Chinese Centenarians

Multi-omics insights implicate the remodeling of the intestinal structure and microbiome in aging

The profile of oral microbiome in Chinese elderly population associated with aging and systemic health status

Exploratory Studies of Oral and Fecal Microbiome in Healthy Human Aging.

Identification of age-associated microbial changes via long-read 16S sequencing

Gut Microbial Features and Circulating Metabolomic Signatures of Frailty in Older Adults

Multi-Omics Analysis Reveals Age-Related Microbial and Metabolite Alterations in Non-Human Primates

Diet-Associated Variability in the Elderly Gut Microbiome

Comprehensive gut microbiota composition and microbial interactions among the three age groups

Mapping the human gut mycobiome in middle-aged and elderly adults: multiomics insights and implications for host metabolic health.

Aging Gut Microbiota Markers, A Chinese Local Study

Sex-specific Aging Patterns of Gut Microbiota Guild in Urban Chinese Adults

Age-related Compositional Changes and Correlations of Gut Microbiome, Serum Metabolome, and Immune Factor in Rats

IDDF2020-ABS-0141 the Gut Microbiome and Serum Metabolome Orchestrate Healthy Aging and Longevity with Novel Implications for Renal Function

Integrative analysis of gut microbiota composition, host colonic gene expression and intraluminal metabolites in aging C57BL/6J mice

Identification of fecal microbiome signatures associated with familial longevity and candidate metabolites for healthy aging

Does Microbiome Contribute to Longevity? Compositional and Functional Differences in Gut Microbiota in Chinese Long-Living (>90 Years) and Elderly (65-74 Years) Adults